Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 87%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,650
Total Claims
$1.4M
Drug Cost
753
Beneficiaries
$1,916
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-54%
Opioid rate vs peers
1.0% vs 2.2% avg
+36%
Cost per patient vs peers
$1,916 vs $1,411 avg
+16%
Brand preference vs peers
12.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.0%
Opioid Rate
151
Opioid Claims
$2,691
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,797 claims · $1.1M
Generic: 12,730 claims · $282K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 201 | $194K |
| Empagliflozin | 115 | $119K |
| Dulaglutide | 77 | $93K |
| Rivaroxaban | 100 | $89K |
| Insulin Glargine,hum.Rec.Anlog | 87 | $53K |
| Semaglutide | 29 | $42K |
| Insulin Lispro | 39 | $41K |
| Insulin Glargine,hum.Rec.Anlog | 29 | $38K |
| Insulin Aspart | 44 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 28 | $27K |
| Semaglutide | 22 | $26K |
| Budesonide/Formoterol Fumarate | 42 | $24K |
| Insulin Detemir | 21 | $23K |
| Dapagliflozin Propanediol | 28 | $22K |
| Cariprazine Hcl | 25 | $17K |
Prescribing Profile
Patient Profile
73
Avg Age
51%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About